ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CYBN Cybin Inc

0.345
-0.0149 (-4.14%)
After Hours
Last Updated: 16:55:32
Delayed by 15 minutes

Period:

Draw Mode:

Volume 2,331,951
Bid Price
Ask Price
News -
Day High 0.3563

Low
0.21

52 Week Range

High
0.738

Day Low 0.338
Company Name Stock Ticker Symbol Market Type
Cybin Inc CYBN AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0149 -4.14% 0.345 16:55:32
Open Price Low Price High Price Close Price Prev Close
0.3563 0.338 0.3563 0.3489 0.3599
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,604 2,331,951 $ 0.3447994 $ 804,055 - 0.21 - 0.738
Last Trade Time Type Quantity Stock Price Currency
16:55:32 formt 111 $ 0.345 USD

Cybin Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
35.92M 256.57M - 0 -47.49M -0.19 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Cybin News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CYBN Message Board. Create One! See More Posts on CYBN Message Board See More Message Board Posts

Historical CYBN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.350.35990.3380.35344581,948,132-0.005-1.43%
1 Month0.35010.380.33030.35356282,645,411-0.0051-1.46%
3 Months0.3470.52240.30810.40149095,261,027-0.002-0.58%
6 Months0.460.570.28310.3979994,364,442-0.115-25.00%
1 Year0.28030.7380.210.42116564,079,0400.064723.08%
3 Years1.523.380.210.65719032,108,124-1.18-77.30%
5 Years0.19583.380.02840.68505851,828,2810.149276.20%

Cybin Description

Cybin is focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders, all protected under its ever-growing IP portfolio.